Position in EXEL
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,457,265
+$2,049,702 QoQ
Shares Held
63,541
+93.6% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#209
of 754 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 14%
Shared 13%
None 74%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $119,351,579 across 51 Biotechnology names. EXEL ranks #4 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
106,967 | $53,133,716 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,731 | $24,150,326 | |
| 3 | ARGX |
Argenx SE
|
3,790 | $3,516,247 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
63,541 | $3,457,265 | |
| 5 | URGN |
UroGen Pharma Ltd.
|
72,286 | $2,660,124 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
10,121 | $2,438,856 | |
| 7 | VCEL |
Vericel Corp
|
51,315 | $2,283,003 | |
| 8 | RPRX |
Royalty Pharma plc
|
29,890 | $1,675,931 |
All Filings in EXEL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,457,265 | 63,541 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $1,407,563 | 32,818 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $1,335,762 | 30,476 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $1,070,619 | 25,923 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $982,630 | 22,292 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $813,789 | 22,042 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $605,026 | 18,169 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $357,876 | 13,791 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $265,437 | 11,813 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $1,356,453 | 57,162 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $218,139 | 9,093 | Shares | Defined | 2024-02-02 | |
| 2022-09-30 | $1,456,891 | 92,914 | Shares | Defined | 2022-10-26 | |
| 2021-12-31 | $380,479 | 20,814 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $431,297 | 20,402 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $368,881 | 20,246 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $447,078 | 19,791 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $394,234 | 19,643 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $500,686 | 20,478 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $487,096 | 20,518 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $370,195 | 21,498 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||